Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Digoxin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Medulloblastoma 1

Interventions

Temozolomide 74 Magnetic Resonance Spectroscopy 65 Radiotherapy 42 Specimen Handling 41 Radiosurgery 29 Bevacizumab 28 Cyclophosphamide 26 pembrolizumab 20 Radiation 20 Blood Specimen Collection 18 Nivolumab 15 fludarabine 14 Irinotecan 14 Lomustine 13 Etoposide 12 Carboplatin 12 Vincristine 11 Pemetrexed 11 Biopsy 10 Surgical Procedures, Operative 9 Ipilimumab 9 lutetium Lu 177 dotatate 8 dinutuximab 8 abemaciclib 8 Fluorodeoxyglucose F18 8 trametinib 7 naxitamab 7 fluciclovine F-18 7 Proton Therapy 7 Magnetic Resonance Imaging 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡